Related Experiment Video
Updated: Feb 10, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Left Atrial Appendage: Embryology, Anatomy, Physiology, Arrhythmia and Therapeutic Intervention
Niyada Naksuk1, Deepak Padmanabhan1, Vidhushei Yogeswaran2
1Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Insights
Left atrial appendage (LAA) occlusion offers an alternative to anticoagulation for stroke prevention in atrial fibrillation (AF). While effective, LAA anatomical variations present challenges for device generalization.
Area of Science:
- Cardiology
- Medical Devices
- Electrophysiology
Background:
- The left atrial appendage (LAA) is a primary source of thromboembolism in atrial fibrillation (AF) patients.
- LAA interventions are emerging as alternatives to long-term anticoagulation for stroke prevention.
- Understanding LAA anatomy and physiology is crucial for developing effective interventions.
Purpose of the Study:
- To review the current landscape of LAA interventions for stroke prevention in nonvalvular AF.
- To discuss the efficacy and limitations of LAA occlusion devices.
- To explore future directions in LAA interventions for both thromboembolism and arrhythmias.
Main Methods:
- Review of randomized controlled trials (PROTECT-AF, PREVAIL) comparing LAA occlusion to warfarin.
- Analysis of LAA anatomical complexity and morphological variations.
- Discussion of various interventional approaches (epicardial, endocardial, surgical) and their implications.
Main Results:
- LAA exclusion with the Watchman device demonstrated non-inferiority to warfarin for stroke prevention.
- Significant morphological variations in LAA structure pose challenges for device applicability.
- LAA isolation for arrhythmias may impair contractility and increase thrombosis risk.
Conclusions:
- LAA occlusion is a viable alternative to anticoagulation for selected AF patients.
- Technological advancements and operator expertise are key to improving interventional outcomes.
- Optimal strategies for LAA-targeted arrhythmias require further investigation, balancing efficacy with thrombosis risk.
Abstract:
Known for the pathological connection to atrial fibrillation (AF), the left atrial appendage (LAA) is the most common source of thromboembolism in patients with AF and may be an arrhythmogenic source for the maintenance of AF. Potential interventions of the LAA for stroke prevention have recently been developed through better understanding its anatomy and physiology. Occlusion of the LAA is an alternative to the use of life-long anticoagulation in selected nonvalvular AF cases. The PROTECT-AF (The WATCHMAN LAA Closure Device for Embolic PROTECTion in Patients with Atrial Fibrillation) and PREVAIL (Randomized Trial of LAA Closure vs. Warfarin for Stroke/Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation) randomized controlled trials demonstrated that LAA exclusion using the Watchman percutaneous device is not inferior to warfarin. However, the appendage is structurally complex and has considerable morphological variations among individuals, and it can be challenging to generalize the device for all patients. Continued technological developments including occlusion/ligation through epicardial, endocardial, or surgical approaches, as well as operator expertise regarding LAA anatomy, physiology, and pathophysiology, should improve interventional outcomes. Furthermore, the optimal strategy for re-entrant tachyarrhythmias arising from LAA remains unknown. Whereas an observational study suggested that LAA isolation was more effective than focal ablation, LAA isolation may be associated with significant impairments in LAA contractility, predisposing individuals to a risk of thrombosis.
More Related Videos
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Overview of Anatomy and Physiology
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Surface Appendages of Archaea
Anatomy of the Heart
Mechanism of Cardiac Arrhythmias

